KAITLIN BEADLES: Open Payments
NPI 1174141238 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,213 in 134 payments from 24 companies in 2025. Trend: 2023 $2,083 · 2024 $2,271 · 2025 $3,213
Food & beverage: $3,213
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 32 | $736 |
| Madrigal Pharmaceuticals | 10 | $345 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $342 |
| Gilead Sciences, Inc. | 10 | $224 |
| Ardelyx, Inc. | 8 | $221 |
| Janssen Biotech, Inc. | 9 | $211 |
| Ipsen Biopharmaceuticals, Inc | 7 | $184 |
| Lilly USA, LLC | 7 | $139 |
| Regeneron Healthcare Solutions, Inc. | 4 | $110 |
| Ferring Pharmaceuticals Inc. | 6 | $108 |
Products named: REZDIFFRA, ENTYVIO, SKYRIZI, RINVOQ, IBSRELA, TREMFYA, IQIRVO, LINZESS.
Industry payments across AZ — which companies pay providers there.
